Dekkers OM - Search Results

1

Sample size importantly limits the usefulness of instrumental variable methods, depending on instrument strength and level of confounding.

Boef AG, Dekkers OM, Vandenbroucke JP, le Cessie S. Boef AG, et al. Among authors: dekkers om. J Clin Epidemiol. 2014 Nov;67(11):1258-64. doi: 10.1016/j.jclinepi.2014.05.019. Epub 2014 Aug 12. J Clin Epidemiol. 2014. PMID: 25124167

2

[Generalizability of therapeutic trials].

Dekkers OM, Vandenbroucke JP. Dekkers OM, et al. Ned Tijdschr Geneeskd. 2007 Oct 6;151(40):2203-6. Ned Tijdschr Geneeskd. 2007. PMID: 17969570 Review. Dutch.

3

Mortality in acromegaly: a metaanalysis.

Dekkers OM, Biermasz NR, Pereira AM, Romijn JA, Vandenbroucke JP. Dekkers OM, et al. J Clin Endocrinol Metab. 2008 Jan;93(1):61-7. doi: 10.1210/jc.2007-1191. Epub 2007 Oct 30. J Clin Endocrinol Metab. 2008. PMID: 17971431

4

A possible overestimation of the effect of aspirin.

Snoep JD, Dekkers OM, Vandenbroucke JP. Snoep JD, et al. Among authors: dekkers om. Arch Intern Med. 2007 Nov 26;167(21):2372-3; author reply 2373. doi: 10.1001/archinte.167.21.2372-b. Arch Intern Med. 2007. PMID: 18040005 No abstract available.

5

How to assess the external validity of therapeutic trials: a conceptual approach.

Dekkers OM, von Elm E, Algra A, Romijn JA, Vandenbroucke JP. Dekkers OM, et al. Int J Epidemiol. 2010 Feb;39(1):89-94. doi: 10.1093/ije/dyp174. Epub 2009 Apr 17. Int J Epidemiol. 2010. PMID: 19376882 Free article.

6

Estimated age- and sex-specific incidence and prevalence of dopamine agonist-treated hyperprolactinemia.

Kars M, Souverein PC, Herings RM, Romijn JA, Vandenbroucke JP, de Boer A, Dekkers OM. Kars M, et al. Among authors: dekkers om. J Clin Endocrinol Metab. 2009 Aug;94(8):2729-34. doi: 10.1210/jc.2009-0177. Epub 2009 Jun 2. J Clin Endocrinol Metab. 2009. PMID: 19491225

7

Clinical outcomes after estimated versus calculated activity of radioiodine for the treatment of hyperthyroidism: systematic review and meta-analysis.

de Rooij A, Vandenbroucke JP, Smit JW, Stokkel MP, Dekkers OM. de Rooij A, et al. Among authors: dekkers om. Eur J Endocrinol. 2009 Nov;161(5):771-7. doi: 10.1530/EJE-09-0286. Epub 2009 Aug 11. Eur J Endocrinol. 2009. PMID: 19671708 Review.

8

The risk for breast cancer is not evidently increased in women with hyperprolactinemia.

Dekkers OM, Romijn JA, de Boer A, Vandenbroucke JP. Dekkers OM, et al. Pituitary. 2010 Sep;13(3):195-8. doi: 10.1007/s11102-009-0214-y. Pituitary. 2010. PMID: 20012697 Free PMC article.

9

Efficacy of experimental treatments compared with standard treatments in non-inferiority trials: a meta-analysis of randomized controlled trials.

Soonawala D, Middelburg RA, Egger M, Vandenbroucke JP, Dekkers OM. Soonawala D, et al. Among authors: dekkers om. Int J Epidemiol. 2010 Dec;39(6):1567-81. doi: 10.1093/ije/dyq136. Epub 2010 Sep 13. Int J Epidemiol. 2010. PMID: 20837637 Free article.

10

Associations between vitamin D receptor genotypes and mortality in a cohort of older Dutch individuals.

de Jongh RT, Lips P, Rijs KJ, van Schoor NM, Kramer MH, Vandenbroucke JP, Dekkers OM. de Jongh RT, et al. Among authors: dekkers om. Eur J Endocrinol. 2011 Jan;164(1):75-82. doi: 10.1530/EJE-10-0688. Epub 2010 Nov 4. Eur J Endocrinol. 2011. PMID: 21051524

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

423 results

Search Page